Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Fragment Screening: Biochemical Assays Versus NMR

The identification of fragment starting points is a key challenge in fragment-based drug discovery; here, screening by biochemical assays is compared with leading biophysical technique of NMR.

Jon Barker, Thomas Hesterkamp, Markus Schade and Mark Whittaker at Evotec (November 2007)

    View full article    |    Back to Analytical Laboratory Technology section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |